ISE Chemicals Corporation (ICHMF)
USD 32.81
(0.0%)
USD 32.81
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 30.96 Million | 16.34 Million | 28.55 Million | 23.09 Million | 24.11 Million |
| Net Income | 26.02 Million | 19.53 Million | 15.4 Million | 13 Million | 10.95 Million |
| Depreciation & Amortization | 13.96 Million | 13.81 Million | 12.93 Million | 12.69 Million | 12.47 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -11.4 Million | -20.37 Million | -1.61 Million | -2.99 Million | 2.03 Million |
| Other non-cash items | 2.38 Million | 3.36 Million | 1.84 Million | 377.74 Thousand | 24.04 Million |
| Investing Cash Flow | -13.54 Million | -16.1 Million | -63.05 Million | -25.27 Million | -17.99 Million |
| Investments in PPE | -13.5 Million | -16.01 Million | -28.63 Million | -25.26 Million | -18.34 Million |
| Acquisitions | 63.78 Thousand | 22.87 Thousand | - | - | 9201.75 |
| Investment purchases | -7.08 Million | -7.62 Million | -34.74 Million | - | -9201.75 |
| Sales/Maturities of investments | 7.08 Million | 7.62 Million | - | - | 368.06 Thousand |
| Other Investing Activities | -99.21 Thousand | -106.73 Thousand | 330.06 Thousand | -9686.00 | -18.4 Thousand |
| Financing Cash Flow | -8.15 Million | -5.77 Million | -4.56 Million | -4.1 Million | -3.18 Million |
| Debt repayment | - | - | - | - | - |
| Dividends payments | -7.94 Million | -5.63 Million | -4.42 Million | -3.94 Million | -3.04 Million |
| Common Stock Repurchased | -49.6 Thousand | -15.24 Thousand | -17.37 Thousand | -9685.70 | -27.6 Thousand |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -155.91 Thousand | -121.98 Thousand | -130.29 Thousand | -154.97 Thousand | -101.21 Thousand |
| Accounts receivables | -3.63 Million | -6.44 Million | -8.87 Million | 1.39 Million | -515.29 Thousand |
| Accounts payables | 4.96 Million | 1.87 Million | 6.43 Million | -106.54 Thousand | 1.34 Million |
| Inventory | -12.86 Million | -13.54 Million | -955.45 Thousand | -4.21 Million | -1.26 Million |
| Other working capital | 134.65 Thousand | -2.26 Million | 1.78 Million | -67.8 Thousand | 2.47 Million |
| Cash at beginning of period | 33.44 Million | 44.03 Million | 94.16 Million | 94.94 Million | 91.18 Million |
| Cash at end of period | 40.53 Million | 33.44 Million | 44.03 Million | 94.16 Million | 94.94 Million |
| Capital Expenditure | -13.5 Million | -16.01 Million | -28.63 Million | -25.26 Million | -18.34 Million |
| Effect of forex changes on cash | 25 Million | 41 Million | -154 Million | 53 Million | -0.72 |
| Net cash flow / Change in cash | 7.09 Million | -10.59 Million | -50.12 Million | -779.27 Thousand | 3.76 Million |
| Free Cash Flow | 17.45 Million | 327.83 Thousand | -78.17 Thousand | -2.17 Million | 5.76 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.37 Billion | 875 Million | 26.02 Million | 1.09 Billion | 729 Million | 1.16 Billion |
| Depreciation & Amortization | - | - | 13.96 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -11.4 Million | - | - | - |
| Other non-cash items | -1.37 Billion | -875 Million | 2.38 Million | -1.09 Billion | -729 Million | -1.16 Billion |
| Investing Cash Flow | - | - | -13.54 Million | - | - | - |
| Investments in PPE | - | - | -13.5 Million | - | - | - |
| Acquisitions | - | - | 63.78 Thousand | - | - | - |
| Investment purchases | - | - | -7.08 Million | - | - | - |
| Sales/Maturities of investments | - | - | 7.08 Million | - | - | - |
| Other Investing Activities | - | - | -99.21 Thousand | - | - | - |
| Financing Cash Flow | - | - | -8.15 Million | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | -7.94 Million | - | - | - |
| Common Stock Repurchased | - | - | -49.6 Thousand | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -155.91 Thousand | - | - | - |
| Accounts receivables | - | - | -3.63 Million | - | - | - |
| Accounts payables | - | - | 4.96 Million | - | - | - |
| Inventory | - | - | -12.86 Million | - | - | - |
| Other working capital | - | - | 134.65 Thousand | - | - | - |
| Cash at beginning of period | - | - | 33.44 Million | - | - | - |
| Cash at end of period | - | - | 40.53 Million | - | - | - |
| Capital Expenditure | - | - | -13.5 Million | - | - | - |
| Effect of forex changes on cash | - | - | 25 Million | - | - | - |
| Net cash flow / Change in cash | - | - | 7.09 Million | - | - | - |
| Free Cash Flow | - | - | 17.45 Million | - | - | - |
002540
CCO
HEADSUP
LOGQ
MPXOF
000120